Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study
Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study
复制标题
α-突触核蛋白聚集体扩增后保留的蛋白酶 K 抗性核心:对疾病相关结构研究的意义
DOI:
10.1016/j.bbrc.2019.11.142
复制
发表时间:
2020
影响因子:
3.1
通讯作者:
Nukina Nobuyuki
中科院分区:
文献类型:
--
作者:
Yoshinaga Saki;Yamanaka Tomoyuki;Miyazaki Haruko;Okuzumi Ayami;Hiyama Akiko;Murayama Shigeo;Nukina Nobuyuki
Many pathological proteins related to neurodegenerative diseases are misfolded, aggregating to form amyloid fibrils during pathogenesis. One of the pathological proteins, alpha-synuclein (α-syn), accumulates in the brains of Parkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), which are designated as synucleinopathies. Recently, structural properties of abnormal accumulated proteins are suggested to determine the disease phenotype. However, the biochemical and structural characteristics of those accumulated proteins are still poorly understood. We previously reported the sequence and seed-structure-dependent polymorphic fibrils of α-syn and the polymorphism was identified by proteinase K-resistant cores determined by mass spectrometry (MS) analysis. In this study, we applied this method to analyze α-syn aggregates of MSA and DLB. To perform MS analysis on proteinase K-resistant cores, we first performed amplification of α-syn aggregates by seeding reaction and protein misfolding cyclic amplification (PMCA) to obtain a sufficient amount of aggregates. Using SDS insoluble fraction of the disease brain, we successfully amplified enough α-syn aggregates for MS analysis. We differentiated between mouse and human α-syn aggregates by MS analysis on proteinase K-resistant cores of the aggregates before and after amplification. The results suggest that structural properties of amplified α-syn fibrils are preserved after PMCA and these methods can be applicable in the study of pathological proteins of the neurodegenerative disorders.